US Stock MarketDetailed Quotes
ALNY Alnylam Pharmaceuticals
- 245.440
- +0.180+0.07%
Close Dec 13 16:00 ET
- 246.570
- +1.130+0.46%
Post 20:01 ET
31.66BMarket Cap-93.68P/E (TTM)
249.510High241.890Low592.05KVolume246.010Open245.260Pre Close145.25MTurnover0.46%Turnover RatioLossP/E (Static)128.98MShares304.39052wk High977.85P/B31.52BFloat Cap141.97552wk Low--Dividend TTM128.43MShs Float304.390Historical High--Div YieldTTM3.11%Amplitude3.650Historical Low245.338Avg Price1Lot Size
Heat List
US
Overall
Symbol
Price
% Chg
No Data
Alnylam Pharmaceuticals Stock Forum
Alnylam Highlights New Data From HELIOS-B Study of Vutrisiran for the Treatment of Transthyretin Amyloidosis With Cardiomyopathy at Heart Failure Society of America Annual Scientific Meeting 2024 | ALNY Stock News
ALNY BUY ALERT 🚨 DRUG NEWS MULTIPLE PRICE TARGET RAISES
No comment yet